1. Home
  2. SPRB vs ANY Comparison

SPRB vs ANY Comparison

Compare SPRB & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRB
  • ANY
  • Stock Information
  • Founded
  • SPRB 2014
  • ANY N/A
  • Country
  • SPRB United States
  • ANY United States
  • Employees
  • SPRB N/A
  • ANY N/A
  • Industry
  • SPRB Medicinal Chemicals and Botanical Products
  • ANY Finance: Consumer Services
  • Sector
  • SPRB Health Care
  • ANY Finance
  • Exchange
  • SPRB Nasdaq
  • ANY Nasdaq
  • Market Cap
  • SPRB 22.8M
  • ANY 22.8M
  • IPO Year
  • SPRB 2020
  • ANY N/A
  • Fundamental
  • Price
  • SPRB $0.52
  • ANY $1.45
  • Analyst Decision
  • SPRB Hold
  • ANY Strong Buy
  • Analyst Count
  • SPRB 7
  • ANY 1
  • Target Price
  • SPRB $2.50
  • ANY $3.00
  • AVG Volume (30 Days)
  • SPRB 400.8K
  • ANY 1.2M
  • Earning Date
  • SPRB 11-11-2024
  • ANY 11-19-2024
  • Dividend Yield
  • SPRB N/A
  • ANY N/A
  • EPS Growth
  • SPRB N/A
  • ANY N/A
  • EPS
  • SPRB N/A
  • ANY N/A
  • Revenue
  • SPRB $7,101,000.00
  • ANY $25,026,000.00
  • Revenue This Year
  • SPRB N/A
  • ANY N/A
  • Revenue Next Year
  • SPRB N/A
  • ANY N/A
  • P/E Ratio
  • SPRB N/A
  • ANY N/A
  • Revenue Growth
  • SPRB N/A
  • ANY 121.94
  • 52 Week Low
  • SPRB $0.41
  • ANY $0.57
  • 52 Week High
  • SPRB $5.95
  • ANY $4.09
  • Technical
  • Relative Strength Index (RSI)
  • SPRB 47.26
  • ANY 62.20
  • Support Level
  • SPRB $0.51
  • ANY $1.00
  • Resistance Level
  • SPRB $0.56
  • ANY $1.90
  • Average True Range (ATR)
  • SPRB 0.03
  • ANY 0.17
  • MACD
  • SPRB -0.01
  • ANY 0.05
  • Stochastic Oscillator
  • SPRB 16.61
  • ANY 50.00

About SPRB Spruce Biosciences Inc.

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Digital Mining and Service and Product. The Digital Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: